MedTrace Logo

Prostate Enucleation With Intravesical Botox Injections in Treating BPH and Bladder Overactivity

NCT05910983 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2024-05-17

No results posted yet for this study

Summary

The aim of this study is to evaluate the effect of intravesical Botox injections on lower urinary tract symptoms (LUTS) when administered during Bipolar prostate enucleation surgery in patients with bladder outlet obstruction (BOO) and overactive bladder symptoms (OAB).

Conditions

  • BPH
  • Intravesical Botox
  • Bipolar Enucleation of the Prostate
  • Overactive Bladder
  • Bladder Outlet Obstruction

Interventions

PROCEDURE

Bipolar enucleation of the prostate (BipolEP)

Bipolar enucleation of the prostate (BipolEP)

DRUG

Intravesical Botox injection

Intravesical botox injection given only in experimental group.100 units of Botox will be used and diluted in 10 mL of normal saline. 0.5 cc injections will be administered in 20 injection sites (trigone sparing).

Sponsors & Collaborators

  • Menoufia University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-01-01
Primary Completion
2025-11-01
Completion
2025-12-01

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05910983 on ClinicalTrials.gov